KyeongJin Kim

1.9k total citations
37 papers, 1.3k citations indexed

About

KyeongJin Kim is a scholar working on Molecular Biology, Epidemiology and Hepatology. According to data from OpenAlex, KyeongJin Kim has authored 37 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 12 papers in Epidemiology and 9 papers in Hepatology. Recurrent topics in KyeongJin Kim's work include Liver Disease Diagnosis and Treatment (10 papers), Peroxisome Proliferator-Activated Receptors (7 papers) and Metabolism, Diabetes, and Cancer (6 papers). KyeongJin Kim is often cited by papers focused on Liver Disease Diagnosis and Treatment (10 papers), Peroxisome Proliferator-Activated Receptors (7 papers) and Metabolism, Diabetes, and Cancer (6 papers). KyeongJin Kim collaborates with scholars based in South Korea, United States and Italy. KyeongJin Kim's co-authors include JaeHun Cheong, Kook Hwan Kim, Utpal B. Pajvani, Luca Valenti, Naoya Sakamoto, Hyeong Hoe Kim, Paola Dongiovanni, Hye Young Kim, Changyu Zhu and Hyun Kook Cho and has published in prestigious journals such as Nature Communications, Gastroenterology and PLoS ONE.

In The Last Decade

KyeongJin Kim

37 papers receiving 1.3k citations

Peers

Countries citing papers authored by KyeongJin Kim

Since Specialization

Citations

This map shows the geographic impact of KyeongJin Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by KyeongJin Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites KyeongJin Kim more than expected).

Fields of papers citing papers by KyeongJin Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by KyeongJin Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by KyeongJin Kim. The network helps show where KyeongJin Kim may publish in the future.

Co-authorship network of co-authors of KyeongJin Kim

This figure shows the co-authorship network connecting the top 25 collaborators of KyeongJin Kim. A scholar is included among the top collaborators of KyeongJin Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with KyeongJin Kim. KyeongJin Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	KCTD17-mediated Ras stabilization promotes hepatocellular carcinoma progression 2024 ·Clinical and Molecular Hepatology ·Young Hoon Jung, (unknown), (unknown), Kyung Hee Jung, Junjie Yu, (unknown), (unknown), (unknown), (unknown), Dongryeol Ryu, Michele Carrer, Utpal B. Pajvani, Sang Bae Lee, Soon‐Sun Hong, KyeongJin Kim	3
2	ChREBP plays a pivotal role in the nutrient-mediated regulation of metabolic gene expression in brown adipose tissue 2024 ·Life Sciences ·(unknown), (unknown), (unknown), Yusra Ahmad, (unknown), (unknown), KyeongJin Kim, Younghoon Jang	2
3	Targeting E3 ubiquitin ligases and their adaptors as a therapeutic strategy for metabolic diseases 2023 ·Experimental & Molecular Medicine ·(unknown), (unknown), Young Hoon Jung, (unknown), (unknown), KyeongJin Kim	20
4	Regulation of CMGC kinases by hypoxia 2023 ·BMB Reports ·KyeongJin Kim, Sang Bae Lee	1
5	Notch-mediated hepatocyte MCP-1 secretion causes liver fibrosis 2023 ·JCI Insight ·(unknown), Jorge Postigo, KyeongJin Kim, Changyu Zhu, Junjie Yu, Marica Meroni, (unknown), Alberto Bartolomé, Dianne H. Dapito, Anthony W. Ferrante, Paola Dongiovanni, Luca Valenti, Rémi J. Creusot, Utpal B. Pajvani	52
6	Regulated interaction of ID2 with the anaphase-promoting complex links progression through mitosis with reactivation of cell-type-specific transcription 2022 ·Nature Communications ·Sang Bae Lee, Luciano Garofano, Aram Ko, Fulvio D’Angelo, Brulinda Frangaj, (unknown), (unknown), KyeongJin Kim, Timothy Cardozo, Antonio Iavarone, Anna Lasorella	3
7	Hepatocyte TLR4 triggers inter-hepatocyte Jagged1/Notch signaling to determine NASH-induced fibrosis 2021 ·Science Translational Medicine ·Junjie Yu, Changyu Zhu, Xiaobo Wang, KyeongJin Kim, Alberto Bartolomé, Paola Dongiovanni, Katherine P. Yates, Luca Valenti, Michele Carrer, Thorsten Sadowski, Li Qiang, Ira Tabas, Joel E. Lavine, Utpal B. Pajvani	94
8	Adipocyte PHLPP2 inhibition prevents obesity-induced fatty liver 2021 ·Nature Communications ·KyeongJin Kim, Jin Ku Kang, Young Hoon Jung, Sang Bae Lee, Raffaela Rametta, Paola Dongiovanni, Luca Valenti, Utpal B. Pajvani	33
9	Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis 2018 ·Science Translational Medicine ·Changyu Zhu, KyeongJin Kim, Xiaobo Wang, Alberto Bartolomé, Marcela Salomao, Paola Dongiovanni, Marica Meroni, Mark J. Graham, Katherine P. Yates, Anna Mae Diehl, Robert F. Schwabe, Ira Tabas, Luca Valenti, Joel E. Lavine, Utpal B. Pajvani	194
10	γ-Secretase Inhibition Lowers Plasma Triglyceride-Rich Lipoproteins by Stabilizing the LDL Receptor 2018 ·Cell Metabolism ·KyeongJin Kim, Ira J. Goldberg, Mark Graham, Meenakshi Sundaram, Enrico Bertaggia, (unknown), Li Qiang, Rebecca A. Haeusler, Daniel Metzger, Pierre Chambon, Zemin Yao, Henry N. Ginsberg, Utpal B. Pajvani	22
11	Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis 2017 ·Gastroenterology ·KyeongJin Kim, Dongryeol Ryu, Paola Dongiovanni, Lale Özcan, Shruti Nayak, Beatrix Ueberheide, Luca Valenti, Johan Auwerx, Utpal B. Pajvani	31
12	mTORC1-independent Raptor prevents hepatic steatosis by stabilizing PHLPP2 2016 ·Nature Communications ·KyeongJin Kim, Li Qiang, Matthew S. Hayden, David P. Sparling, Nicole H. Purcell, Utpal B. Pajvani	54
13	Hepatitis B Virus X Protein Impairs Hepatic Insulin Signaling Through Degradation of IRS1 and Induction of SOCS3 2010 ·PLoS ONE ·KyeongJin Kim, Kook Hwan Kim, JaeHun Cheong	45
14	Hepatitis C virus NS5A protein increases hepatic lipid accumulation via induction of activation and expression of PPARgamma 2009 ·FEBS Letters ·KyeongJin Kim, Kook Hwan Kim, (unknown), Jin Young Park, Naoya Sakamoto, JaeHun Cheong	45
15	Oleic acid inhibits hepatic insulin signaling through deregulation of STAT3 activation and C/EBPα expression 2009 ·Cellular Signalling ·KyeongJin Kim, Hye Young Kim, (unknown), Jeong Heo, JaeHun Cheong	11
16	Homeodomain transcription factor CDX1 is required for the transcriptional induction of PPARγ in intestinal cell differentiation 2008 ·FEBS Letters ·Min Jung Park, Hye Young Kim, KyeongJin Kim, JaeHun Cheong	9
17	Hepatitis B virus X protein induces lipogenic transcription factor SREBP1 and fatty acid synthase through the activation of nuclear receptor LXRα 2008 ·Biochemical Journal ·KyeongJin Kim, Kook Hwan Kim, Hyeong Hoe Kim, JaeHun Cheong	96
18	HCV core protein induces hepatic lipid accumulation by activating SREBP1 and PPARγ 2007 ·Biochemical and Biophysical Research Communications ·Kook Hwan Kim, Sung Pyo Hong, KyeongJin Kim, (unknown), Kwang Jin Kim, JaeHun Cheong	117
19	The incidence and clinical characteristics of symptomatic propylthiouracil-induced hepatic injury in patients with hyperthyroidism: a single-center retrospective study 2001 ·The American Journal of Gastroenterology ·Heejin Kim, (unknown), (unknown), (unknown), KyeongJin Kim, (unknown), Hyo Jong Kim, (unknown), (unknown), Rin Chang	68
20	Dedifferentiation of conditionally immortalized hepatocytes with long-term in vitro passage 2000 ·Experimental & Molecular Medicine ·Byung‐Ho Kim, (unknown), Eun Hee Choi, Young‐Il Kim, KyeongJin Kim, (unknown), Hyo-Jong Kim, (unknown), (unknown), Rin Chang	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact